Shoe Station Group (SHOE) shares were down 19% in premarket activity Thursday following the company's Q2 results.
Biohaven (BHVN) stock was down 13% after the company said the US Food and Drug Administration has instructed the company to pause new patient enrollment for its BHV-7000 studies as of Sept. 4.
Navan (NAVN) shares were 14% lower following the company's fiscal Q2 results and acquisition of events platform BoomPop.
Cooper (COO) stock was 14% lower after multiple analyst price target cuts.
Ribbon Acquisition (RIBB) shares were down 19%, partially reversing the 25% rise from the prior close.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.